Modal close

Dear Democracy Now! visitor,

You turn to Democracy Now! for ad-free news you can trust. Maybe you come for our daily headlines. Maybe you come for in-depth stories that expose corporate and government abuses of power. Democracy Now! brings you crucial reporting like our coverage from the front lines of the Dakota Access pipeline protests or news about this unprecedented US presidential election—and our coverage is never paid for by the oil and gas companies or the campaigns and superPACs. We produce our daily news hour at a fraction of the budget of a commercial news operation—all without ads, government funding or corporate sponsorship. How? This model of news depends on your support. Today, less than 1% of our visitors support Democracy Now! with a donation each year. If even 3% of our website visitors donated just $8 per month, we could cover our basic operating expenses for a year. Pretty amazing right? If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Non-commercial news needs your support.

We rely on contributions from you, our viewers and listeners to do our work. If you visit us daily or weekly or even just once a month, now is a great time to make your monthly contribution.

Please do your part today.

Topics

Act Up Unfurls Banner

July 31, 2000
Story
WATCH FULL SHOW

Early this morning, ACT UP activists dropped a giant banner on a major billboard in Philadelphia to demand that George W. Bush take a stand against high drug prices that, they say, result in the deaths of millions of people with HIV in Africa and worldwide. The banner read: "BUSH AND DRUG COMPANY GREED KILLS: GENERIC AIDS DRUGS FOR AFRICA NOW!"

Guest:

  • Julie Davids, a member of Philadelphia ACT-UP and was one of the participants in the action.

The original content of this program is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License. Please attribute legal copies of this work to democracynow.org. Some of the work(s) that this program incorporates, however, may be separately licensed. For further information or additional permissions, contact us.